1. Kafetzis, D. A., Bryskier, A.: Pediatric use of macrolide antibiotics. In: Macrolides. Chemistry, pharmacology, and clinical uses. Chapter 42. Arnette, 1993, pp. 584–590.
2. Adam, D.: Clinical use of the new macrolides, azalides and streptogramins in pediatrics. J. Chemother. 4 (1992) 371–375.
3. Barlam, T., Neu, H. C.:In vitro comparison of the activity of RU 28965, a new macrolide with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 25 (1984) 529–531.
4. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J., Fernandes, D. B.: Comparativein vitro activities of new 14, 15, and 16 membered macrolides. Antimicrob. Agents Chemother. 32 (1988) 1710–1719.
5. Puri, J. K., Lassman, H. B., Ho, I., Sabo, R., Barey, A.: Safety, tolerance and pharmacokinetics of single and multiple oral doses of RU 28–965 (a new macrolide antibiotic) in healthy men. In:Butzler, J. P., Kobayashi, H. (eds.): Macrolides: a review with an outlook on future developments. Excerpta Medica, Amsterdam, 1985, pp. 128–137.